PubRank

Maxey C M Chung

Author PubWeight™ 49.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Guidelines for the next 10 years of proteomics. Proteomics 2006 3.61
2 Serum autoantibodies as biomarkers for early cancer detection. FEBS J 2009 1.94
3 Anti-cancer properties of anthraquinones from rhubarb. Med Res Rev 2007 1.90
4 "Proteomineering" or not? The debate on biomarker discovery in sera continues. J Proteomics 2011 1.50
5 Membrane proteins and membrane proteomics. Proteomics 2008 1.40
6 Prediction of RNA-binding proteins from primary sequence by a support vector machine approach. RNA 2004 1.36
7 Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells. Mol Cell Proteomics 2008 1.14
8 Effect of training datasets on support vector machine prediction of protein-protein interactions. Proteomics 2005 1.11
9 A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers. Proteomics 2004 1.11
10 Network-based pipeline for analyzing MS data: an application toward liver cancer. J Proteome Res 2011 1.07
11 Separation of human erythrocyte membrane associated proteins with one-dimensional and two-dimensional gel electrophoresis followed by identification with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2002 1.05
12 Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 2005 1.05
13 Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines. J Proteome Res 2011 1.01
14 Cancer proteomics. Mass Spectrom Rev 2012 1.00
15 Subcellular fractionation methods and strategies for proteomics. Proteomics 2010 0.97
16 Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker. J Proteome Res 2012 0.94
17 Troglitazone-induced hepatic mitochondrial proteome expression dynamics in heterozygous Sod2(+/-) mice: two-stage oxidative injury. Toxicol Appl Pharmacol 2008 0.94
18 Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer. J Proteome Res 2012 0.93
19 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis. Proteomics 2008 0.93
20 Identification and functional validation of caldesmon as a potential gastric cancer metastasis-associated protein. J Proteome Res 2013 0.90
21 Proteome analysis of butyrate-treated human colon cancer cells (HT-29). Int J Cancer 2002 0.88
22 Proteomics discovery of biomarkers for mitral regurgitation caused by mitral valve prolapse. J Proteomics 2013 0.87
23 Proteome database of hepatocellular carcinoma. J Chromatogr B Analyt Technol Biomed Life Sci 2002 0.85
24 Critical role of oxidative stress and sustained JNK activation in aloe-emodin-mediated apoptotic cell death in human hepatoma cells. Carcinogenesis 2007 0.84
25 Identification of proteins differentially expressed between capillary endothelial cells of hepatocellular carcinoma and normal liver in an orthotopic rat tumor model using 2-D DIGE. Proteomics 2010 0.84
26 Heart extracellular matrix supports cardiomyocyte differentiation of mouse embryonic stem cells. J Biosci Bioeng 2012 0.83
27 S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis. Proteomics Clin Appl 2012 0.82
28 The Asia Oceania Human Proteome Organisation Membrane Proteomics Initiative. Preparation and characterisation of the carbonate-washed membrane standard. Proteomics 2010 0.82
29 Sieving through the cancer secretome. Biochim Biophys Acta 2013 0.81
30 "The quest for biomarkers": are we on the right technical track? Proteomics Clin Appl 2011 0.81
31 2-D DIGE analysis of butyrate-treated HCT-116 cells after enrichment with heparin affinity chromatography. J Proteome Res 2006 0.80
32 Gastrointestinal fluids proteomics. Proteomics Clin Appl 2007 0.80
33 Proteomic analysis of human gastric juice: a shotgun approach. Proteomics 2010 0.79
34 2D DIGE analysis of serum after fractionation by ProteoMiner™ beads. Methods Mol Biol 2012 0.79
35 Proteomics profiling of hepatic mitochondria in heterozygous Sod2+/- mice, an animal model of discreet mitochondrial oxidative stress. Proteomics 2008 0.78
36 The gastric fluid proteome as a potential source of gastric cancer biomarkers. J Proteomics 2013 0.78
37 beta-Phenylethyl isothiocyanate mediated apoptosis: a proteomic investigation of early apoptotic protein changes. Proteomics 2005 0.78
38 Identification of potential pathways involved in induction of apoptosis by butyrate and 4-benzoylbutyrate in HT29 colorectal cancer cells. J Proteome Res 2012 0.78
39 Chinese human liver proteome project: a pathfinder of HUPO human liver proteome project. J Proteome Res 2010 0.78
40 Effect of snake venom procoagulants on snake plasma: implications for the coagulation cascade of snakes. Toxicon 2002 0.77
41 Integrative toxicoproteomics implicates impaired mitochondrial glutathione import as an off-target effect of troglitazone. J Proteome Res 2013 0.77
42 Proteomic analysis of the oil palm fruit mesocarp reveals elevated oxidative phosphorylation activity is critical for increased storage oil production. J Proteome Res 2013 0.77
43 iTRAQ analysis of colorectal cancer cell lines suggests Drebrin (DBN1) is overexpressed during liver metastasis. Proteomics 2014 0.77
44 iTRAQ™ labeling coupled with LC-MALDI mass spectrometry for monitoring temporal response of colorectal cancer cells to butyrate treatment. Methods Mol Biol 2011 0.77
45 Anticancer effects of aloe-emodin on HepG2 cells: Cellular and proteomic studies. Proteomics Clin Appl 2007 0.76
46 "Proteomineering" serum biomarkers. A study in scarlet. Electrophoresis 2011 0.76
47 The Sod2 mutant mouse as a model for oxidative stress: a functional proteomics perspective. Mass Spectrom Rev 2010 0.76
48 Purpureotin: a novel di-dimeric C-type lectin-like protein from Trimeresurus purpureomaculatus venom is stabilized by noncovalent interactions. Arch Biochem Biophys 2004 0.76
49 Cibacron Blue and proteomics: the mystery of the platoon missing in action. J Proteomics 2011 0.75
50 A network-based maximum link approach towards MS identifies potentially important roles for undetected ARRB1/2 and ACTB in liver cancer progression. Int J Bioinform Res Appl 2012 0.75
51 Genomic and proteomic perspectives in cell culture engineering. J Biotechnol 2002 0.75
52 SPLASH: systematic proteomics laboratory analysis and storage hub. Proteomics 2006 0.75
53 Chromosome-centric Human Proteome Project (C-HPP): Chromosome 12. J Proteome Res 2014 0.75